New 'Living Drug' trial targets advanced colon cancer
Disease control
Recruiting now
This early-stage study is testing a new type of personalized cell therapy called CNA3103 for adults with metastatic colorectal cancer that has spread. Doctors will collect a patient's own immune cells, modify them in a lab to target a specific protein (LGR5) on cancer cells, and …
Phase: PHASE1, PHASE2 • Sponsor: Carina Biotech Limited • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC